Tarsus Pharmaceuticals
TARS
TARS
191 hedge funds and large institutions have $2.24B invested in Tarsus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 66 increasing their positions, 71 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
-2
Holders Change %
-1.04%
% of All Funds
2.59%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.1%
New
35
Increased
66
Reduced
71
Closed
34
Calls
$1.39M
Puts
$627K
Net Calls
+$764K
Net Calls Change
+$13.7M
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$76.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$46.9M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$36.9M |
| 4 |
O
OrbiMed
New York
|
+$33.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$26.2M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$20.4M |
| 2 |
BlackRock
New York
|
-$19.8M |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$17.6M |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$12.4M |
| 5 |
PA
Perceptive Advisors
New York
|
-$10.3M |